{"id":578842,"date":"2021-12-13T13:00:02","date_gmt":"2021-12-13T13:00:02","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=578842"},"modified":"2021-12-13T13:00:02","modified_gmt":"2021-12-13T13:00:02","slug":"acute-pain-market-analysis-insights-into-epidemiology-segmentation-treatment-landscape-pipeline-therapies-and-key-companies","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/acute-pain-market-analysis-insights-into-epidemiology-segmentation-treatment-landscape-pipeline-therapies-and-key-companies_578842.html","title":{"rendered":"Acute Pain Market Analysis: Insights into Epidemiology Segmentation, Treatment Landscape, Pipeline Therapies and Key Companies"},"content":{"rendered":"<div style=\"float:right; width:250px; padding:8px 10px 10px 10px;\">\n<div><a href=\"https:\/\/www.abnewswire.com\/uploads\/1639380377.png\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Acute Pain Market Analysis: Insights into Epidemiology Segmentation, Treatment Landscape, Pipeline Therapies and Key Companies\" src=\"https:\/\/www.abnewswire.com\/uploads\/1639380377.png\" alt=\"Acute Pain Market Analysis: Insights into Epidemiology Segmentation, Treatment Landscape, Pipeline Therapies and Key Companies\" width=\"225\" height=\"225\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/div>\n<div class=\"quotes\">\n<div>Acute Pain Market <\/div>\n<\/div>\n<\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">The Acute Pain market will grow during the forecast period as a result of increased R&#038;D activities and a larger patient pool.<\/div>\n<p style=\"text-align: justify;\">DelveInsight&rsquo;s <strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/acute-pain-market?utm_source=Abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=spr\">Acute Pain market report<\/a><\/strong> offers comprehensive coverage of the current treatment practices, pipeline therapies, and market share of the individual drug, current and forecasted Acute Pain market size from 2018 to 2030 in the 7MM.<\/p>\n<p style=\"text-align: justify;\"><strong>Some of the Key Highlights from the Acute Pain Market Report<\/strong>&nbsp;<\/p>\n<ul style=\"text-align: justify;\">\n<li>As per DelveInsight estimates, the Acute Pain patient pool was <strong>91,011,151<\/strong> in the US in 2020.<\/li>\n<li>DelveInsight&#8217;s analysts discovered that patients with moderate pain accounted for the largest patient pool, followed by patients with mild pain, and those with severe pain accounted for the smallest patient pool.<\/li>\n<li>Leading companies in the Acute Pain market include <strong>Charleston Laboratories, Neumentum, Neurana Pharmaceuticals<\/strong>, and others.&nbsp;<\/li>\n<li>Key Acute Pain therapies in the pipeline include <strong>CL-108, NTM-001, Omzya,<\/strong> and others.&nbsp;<\/li>\n<li><strong>Neumentum<\/strong> is working on <strong>NTM-001,<\/strong> the primary product candidate. It is an alcohol-free formulation of the potent nonsteroidal anti-inflammatory drug (NSAID) ketorolac in a pre-mixed bag designed for continuous infusion for 24 hours following surgery.<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">For further information related to disease, request for the sample @ <strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/acute-pain-market?utm_source=Abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=spr\">Acute Pain Market Outlook<\/a>&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Acute Pain Overview<\/strong><\/p>\n<p style=\"text-align: justify;\">Acute pain is defined as &#8220;an expected physiologic response to injurious stimuli that can become pathologic, is typically sudden in onset, time-limited, and motivates behaviours to avoid actual or potential tissue injuries.&#8221;<\/p>\n<p style=\"text-align: justify;\"><strong>Acute Pain Epidemiology Segmentation<\/strong><\/p>\n<p style=\"text-align: justify;\">The Acute Pain report proffers epidemiological analysis for the study period 2018-30 in the 7MM segmented into:<\/p>\n<ul style=\"text-align: justify;\">\n<li>Acute Pain Total Patient Pool<\/li>\n<li>Acute Pain Severity-Specific Patient Pool<\/li>\n<li>Acute Pain Treatable Cases&nbsp;<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>Acute Pain Treatment Landscape&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>NSAIDs and opioids<\/strong> are currently recommended for Acute Pain treatment, but their overuse is a major concern that must be addressed. In the previous few years, the USFDA approved drugs such as <strong>Dsuvia (AcelRx Pharmaceuticals), Ubrogepant (Allergan), Zynrelef (Heron Therapeutics), and Olinvyk injection (Trevena)<\/strong> for treatment of acute pain-related conditions.<\/p>\n<p style=\"text-align: justify;\"><strong>Acute Pain Market Outlook<\/strong><\/p>\n<p style=\"text-align: justify;\">The Acute Pain market will grow during the forecast period as a result of increased R&amp;D activities and a larger patient pool. Pharmaceutical companies are working to develop potential therapies for acute pain in order to meet the unmet medical needs of the currently available therapeutics.<\/p>\n<p style=\"text-align: justify;\">Get a detailed analysis of the market @ <strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/acute-pain-market?utm_source=Abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=spr\">Acute Pain Market Analysis<\/a>&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Acute Pain Pipeline Therapies and Key Companies<\/strong>&nbsp;<\/p>\n<ul style=\"text-align: justify;\">\n<li>CL-108: Charleston Laboratories<\/li>\n<li>NTM-001: Neumentum<\/li>\n<li>Omzya: Neurana Pharmaceuticals<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>Table of Contents<\/strong>&nbsp;<\/p>\n<table border=\"0\" cellpadding=\"0\">\n<tbody>\n<tr>\n<td>\n<p>1.<\/p>\n<\/td>\n<td>\n<p>Key Insights<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p>2.<\/p>\n<\/td>\n<td>\n<p>Acute Pain Market Overview at a Glance<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p>3.<\/p>\n<\/td>\n<td>\n<p>Acute Pain: Disease Background and Overview<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p>4.<\/p>\n<\/td>\n<td>\n<p>Epidemiology and Patient Population<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p>5.<\/p>\n<\/td>\n<td>\n<p>Acute Pain: Country-Wise Epidemiology<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p>6.<\/p>\n<\/td>\n<td>\n<p>Treatment Algorithm, Current Treatment, and Medical Practices<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p>7.<\/p>\n<\/td>\n<td>\n<p>Marketed Drugs<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p>8.<\/p>\n<\/td>\n<td>\n<p>Emerging Therapies<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p>9.<\/p>\n<\/td>\n<td>\n<p>Acute Pain: Market Analysis<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p>10.<\/p>\n<\/td>\n<td>\n<p>Market Drivers<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p>11.<\/p>\n<\/td>\n<td>\n<p>Market Barriers<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p>12.<\/p>\n<\/td>\n<td>\n<p>SWOT Analysis<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p>13.<\/p>\n<\/td>\n<td>\n<p>Unmet Needs<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p>14.<\/p>\n<\/td>\n<td>\n<p>Market Access and Reimbursement&nbsp;<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p>15.<\/p>\n<\/td>\n<td>\n<p>Appendix<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p>16.<\/p>\n<\/td>\n<td>\n<p>Report Methodology<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p>17.<\/p>\n<\/td>\n<td>\n<p>DelveInsight Capabilities<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p>18.<\/p>\n<\/td>\n<td>\n<p>Disclaimer<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p>19.<\/p>\n<\/td>\n<td>\n<p>About DelveInsight<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p style=\"text-align: justify;\">Get in touch with our business executive for <strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/consulting\/due-diligence-services?utm_source=Abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=spr\">Healthcare Due Diligence Services<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Related Reports<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/acute-ocular-pain-market?utm_source=Abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=spr\">Acute Ocular Pain Market<\/a><\/strong>&nbsp;<\/p>\n<p style=\"text-align: justify;\">Get a comprehensive analysis of Acute Ocular Pain pipeline therapies and key companies such as <strong>Ocular Therapeutix, Kala Pharmaceuticals, Sun Pharmaceutical, Bausch &amp; Lomb, Formosa Pharmaceuticals, Sylentis,<\/strong> among others.<\/p>\n<p style=\"text-align: justify;\"><strong>About DelveInsight<\/strong><\/p>\n<p style=\"text-align: justify;\">DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.<\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/delveinsight.com\/_57048.html\" rel=\"nofollow\">DelveInsight Business Research LLP<\/a><br \/><strong>Contact Person:<\/strong> Sandeep Joshi<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=acute-pain-market-analysis-insights-into-epidemiology-segmentation-treatment-landscape-pipeline-therapies-and-key-companies\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> 9193216187<br \/><strong>Address:<\/strong>304 S. Jones Blvd #2432  <br \/><strong>City:<\/strong> Las Vegas<br \/><strong>State:<\/strong> NV<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"http:\/\/www.delveinsight.com\/\" target=\"_blank\" rel=\"nofollow\">www.delveinsight.com\/<\/a><\/p>\n<p><object type=\"text\/html\" data=\"http:\/\/www.delveinsight.com\/\" style=\"width:900px; height:400px;\"><\/object><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=acute-pain-market-analysis-insights-into-epidemiology-segmentation-treatment-landscape-pipeline-therapies-and-key-companies\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Acute Pain Market The Acute Pain market will grow during the forecast period as a result of increased R&#038;D activities and a larger patient pool. DelveInsight&rsquo;s Acute Pain market report offers comprehensive coverage of the current treatment practices, pipeline therapies, &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/acute-pain-market-analysis-insights-into-epidemiology-segmentation-treatment-landscape-pipeline-therapies-and-key-companies_578842.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[405,406,411,403,404],"tags":[],"class_list":["post-578842","post","type-post","status-publish","format-standard","hentry","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-Technology","category-UK","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/578842","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=578842"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/578842\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=578842"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=578842"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=578842"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}